Income reliability
Payout depends on structure rules
PRM.TO is structure-sensitive. The payout may look regular, but coverage tests and distribution conditions matter more than cadence alone.
Big Pharma Split Corp.
Market Snapshot
$14.70
+$0.00 (0.00%)
Toronto
Yield
N/A
Rate $1.24
Next Payment
Payment date passed
Ex-date 2026-06-30
52wk Position
82.53%
-5.16% below high
Updated just now
Decision Area
Payout history, default DRIP coverage, and price creep pressure using market data where available.
Distribution Chart
Coverage Ratio Test
Rung failed. Restore immediately or rebalance the holding.
Price Creep
Smart Recommendation
PRM.TO is not defended at these inputs; top up shares, lower TPR, or test alternatives.
Research Signals
DRIP availability
Pending
Tax character
Pending
Distribution history
Pending
Structure Overview
This is a split-share corporation, which separates the capital appreciation and dividend income of an underlying equity portfolio between two share classes: preferred shares (priority distributions) and capital shares (residual income and NAV growth). The leverage embedded in the capital-share structure amplifies both gains and losses; distributions can be suspended if the coverage ratio falls below regulatory thresholds.
Canadian Planning Notes
Market Facts
A factual market, distribution, valuation, and financial snapshot for this holding.
Canadian Context
Account placement
TFSA
Mixed-character distributions are usually easiest to handle in a TFSA because annual tax reporting is avoided.
RRSP: Also shelters distribution complexity.
Non-registered: Review T3 or issuer tax breakdown before using a taxable account.
Eligible dividend tax credit
Broker DRIP status
Questrade
Available
Wealthsimple
Available
RBC Direct Investing
Available
TD Direct Investing
Available
Run Your Numbers
Use a planning tool that matches this holding's structure, payout timing, and income use case.
Related Holdings
This profile is informational only and does not constitute licensed financial advice. Signal values, planning notes, market data, and structure summaries may not reflect the most current issuer disclosures. Always verify current payout policy, ex-dividend dates, financial statements, and issuer communications before making any investment decision.